| UniProt ID | BUB3_HUMAN | |
|---|---|---|
| UniProt AC | O43684 | |
| Protein Name | Mitotic checkpoint protein BUB3 | |
| Gene Name | BUB3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 328 | |
| Subcellular Localization | Nucleus. Chromosome, centromere, kinetochore. Starts to localize at kinetochores in prometaphase I (Pro-MI) stage and maintains the localization until the metaphase I-anaphase I (MI-AI) transition.. | |
| Protein Description | Has a dual function in spindle-assembly checkpoint signaling and in promoting the establishment of correct kinetochore-microtubule (K-MT) attachments. Promotes the formation of stable end-on bipolar attachments. Necessary for kinetochore localization of BUB1. Regulates chromosome segregation during oocyte meiosis. The BUB1/BUB3 complex plays a role in the inhibition of anaphase-promoting complex or cyclosome (APC/C) when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1.. | |
| Protein Sequence | MTGSNEFKLNQPPEDGISSVKFSPNTSQFLLVSSWDTSVRLYDVPANSMRLKYQHTGAVLDCAFYDPTHAWSGGLDHQLKMHDLNTDQENLVGTHDAPIRCVEYCPEVNVMVTGSWDQTVKLWDPRTPCNAGTFSQPEKVYTLSVSGDRLIVGTAGRRVLVWDLRNMGYVQQRRESSLKYQTRCIRAFPNKQGYVLSSIEGRVAVEYLDPSPEVQKKKYAFKCHRLKENNIEQIYPVNAISFHNIHNTFATGGSDGFVNIWDPFNKKRLCQFHRYPTSIASLAFSNDGTTLAIASSYMYEMDDTEHPEDGIFIRQVTDAETKPKSPCT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTGSNEFKL ------CCCCCCCCC | 49.68 | 23312004 | |
| 4 | Phosphorylation | ----MTGSNEFKLNQ ----CCCCCCCCCCC | 24.82 | 23312004 | |
| 8 | Sumoylation | MTGSNEFKLNQPPED CCCCCCCCCCCCCCC | 40.11 | - | |
| 8 | Sumoylation | MTGSNEFKLNQPPED CCCCCCCCCCCCCCC | 40.11 | - | |
| 8 | Ubiquitination | MTGSNEFKLNQPPED CCCCCCCCCCCCCCC | 40.11 | - | |
| 18 | Phosphorylation | QPPEDGISSVKFSPN CCCCCCCCCEEECCC | 34.31 | 21712546 | |
| 19 | Phosphorylation | PPEDGISSVKFSPNT CCCCCCCCEEECCCC | 27.66 | 20057499 | |
| 21 | Ubiquitination | EDGISSVKFSPNTSQ CCCCCCEEECCCCCC | 41.91 | 21906983 | |
| 23 | Phosphorylation | GISSVKFSPNTSQFL CCCCEEECCCCCCEE | 16.12 | 28348404 | |
| 26 | Phosphorylation | SVKFSPNTSQFLLVS CEEECCCCCCEEEEE | 27.56 | 28348404 | |
| 27 | Phosphorylation | VKFSPNTSQFLLVSS EEECCCCCCEEEEEE | 26.10 | 28348404 | |
| 33 | Phosphorylation | TSQFLLVSSWDTSVR CCCEEEEEECCCEEE | 26.19 | - | |
| 42 | Phosphorylation | WDTSVRLYDVPANSM CCCEEEEEECCCCCC | 12.34 | 27642862 | |
| 48 | Phosphorylation | LYDVPANSMRLKYQH EEECCCCCCEEEEEE | 13.85 | - | |
| 52 | Ubiquitination | PANSMRLKYQHTGAV CCCCCEEEEEECCCE | 32.28 | 21906983 | |
| 52 | Acetylation | PANSMRLKYQHTGAV CCCCCEEEEEECCCE | 32.28 | 25953088 | |
| 80 | Ubiquitination | GGLDHQLKMHDLNTD CCHHHEEEECCCCCC | 27.84 | - | |
| 86 | Phosphorylation | LKMHDLNTDQENLVG EEECCCCCCCHHCCC | 46.48 | - | |
| 126 | Methylation | TVKLWDPRTPCNAGT EEEEECCCCCCCCCC | 49.15 | - | |
| 127 | Phosphorylation | VKLWDPRTPCNAGTF EEEECCCCCCCCCCC | 37.27 | 27273156 | |
| 129 | S-nitrosylation | LWDPRTPCNAGTFSQ EECCCCCCCCCCCCC | 5.57 | 2212679 | |
| 139 | Acetylation | GTFSQPEKVYTLSVS CCCCCCCEEEEEEEC | 47.42 | 25953088 | |
| 139 | Ubiquitination | GTFSQPEKVYTLSVS CCCCCCCEEEEEEEC | 47.42 | 21906983 | |
| 141 | Phosphorylation | FSQPEKVYTLSVSGD CCCCCEEEEEEECCC | 17.03 | 28152594 | |
| 142 | Phosphorylation | SQPEKVYTLSVSGDR CCCCEEEEEEECCCE | 18.62 | 28152594 | |
| 144 | Phosphorylation | PEKVYTLSVSGDRLI CCEEEEEEECCCEEE | 13.36 | 28152594 | |
| 146 | Phosphorylation | KVYTLSVSGDRLIVG EEEEEEECCCEEEEE | 31.44 | 28152594 | |
| 149 | Methylation | TLSVSGDRLIVGTAG EEEECCCEEEEECCC | 29.82 | - | |
| 154 | Phosphorylation | GDRLIVGTAGRRVLV CCEEEEECCCCEEEE | 18.29 | 22817900 | |
| 169 | Nitration | WDLRNMGYVQQRRES EECCCCCHHHHHHHC | 5.59 | - | |
| 179 | Ubiquitination | QRRESSLKYQTRCIR HHHHCCCHHHHHEEE | 36.94 | 19608861 | |
| 179 | 2-Hydroxyisobutyrylation | QRRESSLKYQTRCIR HHHHCCCHHHHHEEE | 36.94 | - | |
| 179 | Acetylation | QRRESSLKYQTRCIR HHHHCCCHHHHHEEE | 36.94 | 19608861 | |
| 179 (in isoform 2) | Ubiquitination | - | 36.94 | - | |
| 186 | Methylation | KYQTRCIRAFPNKQG HHHHHEEECCCCCCC | 33.53 | - | |
| 191 | Ubiquitination | CIRAFPNKQGYVLSS EEECCCCCCCEEEEE | 45.39 | 21906983 | |
| 191 | Ubiquitination | CIRAFPNKQGYVLSS EEECCCCCCCEEEEE | 45.39 | 21890473 | |
| 191 | 2-Hydroxyisobutyrylation | CIRAFPNKQGYVLSS EEECCCCCCCEEEEE | 45.39 | - | |
| 191 (in isoform 2) | Ubiquitination | - | 45.39 | - | |
| 191 | Acetylation | CIRAFPNKQGYVLSS EEECCCCCCCEEEEE | 45.39 | 26051181 | |
| 194 | Phosphorylation | AFPNKQGYVLSSIEG CCCCCCCEEEEEEEC | 8.84 | 24043423 | |
| 197 | Phosphorylation | NKQGYVLSSIEGRVA CCCCEEEEEEECEEE | 21.16 | 24043423 | |
| 198 | Phosphorylation | KQGYVLSSIEGRVAV CCCEEEEEEECEEEE | 22.09 | 24043423 | |
| 207 | Phosphorylation | EGRVAVEYLDPSPEV ECEEEEEECCCCHHH | 15.14 | 30266825 | |
| 207 | Nitration | EGRVAVEYLDPSPEV ECEEEEEECCCCHHH | 15.14 | - | |
| 211 | Phosphorylation | AVEYLDPSPEVQKKK EEEECCCCHHHHHHH | 33.10 | 19664994 | |
| 216 | Acetylation | DPSPEVQKKKYAFKC CCCHHHHHHHHEEEC | 57.31 | 23954790 | |
| 216 | Malonylation | DPSPEVQKKKYAFKC CCCHHHHHHHHEEEC | 57.31 | 26320211 | |
| 216 (in isoform 2) | Ubiquitination | - | 57.31 | - | |
| 216 | 2-Hydroxyisobutyrylation | DPSPEVQKKKYAFKC CCCHHHHHHHHEEEC | 57.31 | - | |
| 216 | Ubiquitination | DPSPEVQKKKYAFKC CCCHHHHHHHHEEEC | 57.31 | 18781797 | |
| 217 | Ubiquitination | PSPEVQKKKYAFKCH CCHHHHHHHHEEECC | 33.65 | - | |
| 218 | Ubiquitination | SPEVQKKKYAFKCHR CHHHHHHHHEEECCC | 49.17 | - | |
| 222 | Ubiquitination | QKKKYAFKCHRLKEN HHHHHEEECCCCCCC | 22.44 | - | |
| 222 | Acetylation | QKKKYAFKCHRLKEN HHHHHEEECCCCCCC | 22.44 | 25953088 | |
| 222 | 2-Hydroxyisobutyrylation | QKKKYAFKCHRLKEN HHHHHEEECCCCCCC | 22.44 | - | |
| 227 | Ubiquitination | AFKCHRLKENNIEQI EEECCCCCCCCCEEE | 59.35 | - | |
| 227 (in isoform 2) | Ubiquitination | - | 59.35 | - | |
| 227 | Sumoylation | AFKCHRLKENNIEQI EEECCCCCCCCCEEE | 59.35 | - | |
| 227 | Acetylation | AFKCHRLKENNIEQI EEECCCCCCCCCEEE | 59.35 | 26051181 | |
| 266 | Ubiquitination | NIWDPFNKKRLCQFH CCCCCCCCCCCCHHC | 39.38 | - | |
| 317 | Phosphorylation | GIFIRQVTDAETKPK CEEEEEECCCCCCCC | 22.58 | 23403867 | |
| 321 | Phosphorylation | RQVTDAETKPKSPCT EEECCCCCCCCCCCC | 55.13 | 23403867 | |
| 322 | Ubiquitination | QVTDAETKPKSPCT- EECCCCCCCCCCCC- | 41.79 | 21906983 | |
| 322 | Sumoylation | QVTDAETKPKSPCT- EECCCCCCCCCCCC- | 41.79 | - | |
| 322 | Sumoylation | QVTDAETKPKSPCT- EECCCCCCCCCCCC- | 41.79 | - | |
| 322 | Acetylation | QVTDAETKPKSPCT- EECCCCCCCCCCCC- | 41.79 | 23749302 | |
| 322 (in isoform 2) | Ubiquitination | - | 41.79 | - | |
| 324 | Ubiquitination | TDAETKPKSPCT--- CCCCCCCCCCCC--- | 69.46 | - | |
| 324 (in isoform 2) | Ubiquitination | - | 69.46 | - | |
| 325 | Phosphorylation | DAETKPKSPCT---- CCCCCCCCCCC---- | 33.46 | 23401153 | |
| 328 | Phosphorylation | TKPKSPCT------- CCCCCCCC------- | 45.06 | 23403867 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BUB3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BUB3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-179, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211, AND MASSSPECTROMETRY. | |
| Ubiquitylation | |
| Reference | PubMed |
| "Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-216, AND MASSSPECTROMETRY. | |